Medtronic's obesity device falls short in US trial, PMA submission faces delay
This article was originally published in Clinica
Executive Summary
Medtronic has suffered a delay in taking to the US a pacemaker-like implant for treating obesity, after the product failed to prove any more effective than a placebo in a year-long trial.